- Research article
- Open Access
The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting ipsilateral renal function after partial nephrectomy
BMC Urology volume 19, Article number: 72 (2019)
Functional outcome is an important issue in nephron-sparing surgery. Various nephrometries have been developed to predict renal function preservation. The aim of this study was to examine the applicability of R.E.N.A.L., PADUA, C-index, and mathematical tumor contact surface area (CSA) in predicting ipsilateral renal function after partial nephrectomy using radio-isotope scans.
We performed this retrospective study in patients who underwent partial nephrectomy between May 2013 and April 2017, and used abdominopelvic computerized tomography or magnetic resonance imaging to obtain R.E.N.A.L., C-index, and CSA. Renal function was measured by 99mTc mercaptoacetyltriglycine (MAG3). We evaluated correlations between nephrometries and perioperative parameters, and comparatively analyzed different nephrometries to determine the predictive ability in the percent change of effective renal plasma flow of the affected kidney.
Three, two, and 35 patients received partial nephrectomy in open, laparoscopic, and robotic approaches, respectively. The median (IQR) tumor size was 3.13 (2.4) cm. The median (IQR) R.E.N.A.L., PADUA, C-index, and CSA scores were 7 (3), 8 (2), 2.01 (1.87), and 14.14 (19.25) cm2, respectively. Spearman correlation analysis showed that four nephrometries were correlated with each other. The strongest correlations were between CSA and C-index (coefficient: − 0.885, p < 0.001), followed by R.E.N.A.L. and PADUA (coefficient: 0.778, p < 0.001). Ischemia time was significantly correlated with R.EN.A.L. (coefficient: 0.35, p = 0.025), PADUA (coefficient: 0.42, p = 0.007), C-index (coefficient: − 0.45, p = 0.004), and CSA (coefficient: 0.41, p = 0.009). In multivariate analysis, PADUA significantly affected ischemia time (p = 0.04). The percent change in effective renal plasma flow (PCE) of the operated kidney was correlated with PADUA (coefficient: 0.48 p = 0.002), C-index (coefficient: − 0.74, p < 0.001), and CSA (coefficient: 0.75, p < 0.001). Only CSA and C-index independently affected PCE (both p < 0.05) in multivariate analysis. In ROC curve analysis, both C-index and CSA could predict 20% change in effective renal plasma flow (AUC: 0.91 vs 0.86, p = 0.2) of the affected kidney.
We suggest using PADUA to evaluate surgical complexity and ischemia time. Regarding the accuracy of the prediction of post-operative ipsilateral renal function, both CSA and C-index outperformed R.E.N.A.L. and PADUA nephrometries.
Partial nephrectomy (PN) is the gold standard treatment for T1 renal tumors and even some T2 renal tumors in present clinical practice [1, 2]. Compared to radical nephrectomy, PN can decrease the incidence of renal dysfunction which may lower the incidence of non-cancer mortality [3, 4]. In order to improve rates of achieving of trifecta or pentafecta in PN, comprehensive evaluation of the tumor’s complexity is necessary before surgery. Therefore, using an adequate tool to evaluate the feasibility of PN and even predict the post-operative outcome is a critical issue in the treatment of localized renal tumors.
Various nephrometry systems have proposed to standardize the description and academic recording of renal tumors. The R.E.N.A.L. nephrometry system was the first to be proposed, followed by the PADUA classification system. These two systems use similar semi-quantitative anatomical factors and methodologies [5, 6]. In the contrast, C-index and mathematical tumor contact surface area (CSA) yield continuous variables which describe the geometric relationship between the tumor and kidney [7, 8]. These four nephrometry systems have been validated externally and they have all been associated with peri-operative outcomes [8,9,10].
Previous studies have tried to clarify the correlations between nephrometry systems and global functional outcomes assessed by estimated glomerular filtration rate (eGFR) [9, 11]. However inconsistencies and inaccuracies have been reported when using eGFR in patients undergoing PN because of compensatory hypertrophy of the contralateral kidney . Split renal function assessed by radio-isotope scans has been shown to be more precise than eGFR to estimate renal function [13, 14]. In addition 99mTc mercaptoacetyltriglycine (MAG3) is preferred over 99mTc diethylene triamine penta-acetic acid (DTPA) in patients with impaired renal function.. R.E.N.A.L. score and its individual constituents “R,E,N” have been reported to be relevant to ipsilateral post-operative renal function (IPRF) . However, little is known about head-to-head comparisons of the predictive ability of IPRF using different nephrometries. In this study, we aimed to evaluate correlations between R.E.N.A.L, PADUA, C-index, and CSA and perioperative and renal functional outcomes assessed by radio-isotope scans.
Patients and data collection
After Institutional Review Board approval, we evaluated consecutive patients who underwent PN via open (OPN), laparoscopic (LPN), or robotic assisted (RPN) approaches for localized renal tumors between May 2013 and April 2017 at a tertiary referral center. We excluded patients with multiple renal tumors within one kidney, solitary kidneys, or end-stage kidney disease. The choice of surgical approach and resection and repair techniques were based on the surgeons’ expertise and the patients’ preference. All PN procedures were performed with the conventional on-clamp technique with clamping of both the renal artery and renal vein. All of the patients had pre-operative imaging with either computed tomography or magnetic resonance imaging. Cold ischemia was used only in OPN, and warm ischemia was used in both LPN and RPN. The patients’ demographics, clinical data, and imaging studies were obtained electronically and analyzed retrospectively.
Preoperative demographics data (sex, age, American Society of Anesthesiologists score, Charlson Comorbidity Index), perioperative outcomes (operative time, ischemia time, estimated blood loss, perioperative complications, length of hospitalization), and pathology features were recorded and evaluated. Nephrometry score including R.E.N.A.L., PADUA, C-index, CSA were obtained according to the original studies [5,6,7,8]. Global renal function was assessed according to eGFR. Split renal function represented by effective renal plasma flow (ERPF) was measured by 99mTc-MAG3 pre-operatively and 1 year after surgery. IPRF was reported as the absolute change of ERPF (ACE), and percent change of ERPF (PCE) of the operated kidney.
Continuous variables are shown as median (IQR). Categorical variables, including those with a > 20% change of ERPF (PCE20) are shown as percentage. Spearman correlation analysis was used to evaluate the relationships among R.E.N.A.L. score, PADUA, C-index, and CSA and perioperative outcomes. Univariate and multivariate analyses of various clinical variables including nephrometries and PCE of the operated kidney were performed using linear regression models. The predive ability of nephrometries for PCE of the operated kidney was evaluated and compared using ROC curve analysis. All analyses was performed using SPSS v.22 (SPSS,Chicago,IL,USA), and a P value < 0.05 was considered to be statistically significant.
Three, two, and 35 patients received PN via open, laparoscopic, and robotic approaches, respectively. The median (IQR) tumor size was 3.13 (2.4) cm. The median (IQR) R.E.N.A.L., PADUA, C-index, and CSA were 7 (3), 8 (2), 2.01 (1.87), and 14.14 (19.25) cm2, respectively. The median (IQR) cold ischemia times and warm ischemia times were 28 (3) minutes and 20.5 (6.38) minutes, respectively (Table 1). The overall complication rate was 22.5%. Of the complications, four patients had urinary infections, two had pneumonia which was cured by antibiotics, two had anemia and received blood transfusions and 1 had a stress ulcer which was treated with a proton pump inhibitor. None of the patients had Clavien-Dindo grade 3 or higher complications. Pathological features demonstrated that renal cell carcinoma accounted for 57.5% of all tumors. Among them, 69.6% were pT1a, 21.7% were pT1b, and 8.7% were pT2 (Table 2).
The median (IQR) time from preoperative ERPF to surgery was 15 (8) days, and the median (IQR) time from surgery to postoperative ERPF was 15 (1.5) months. The median (IQR) ACE was 47.65 (69.39) ml/min/1.73 m2, and the median (IQR) PCE was 22.16 (34.45) % (Table 2). Spearman correlation analysis showed that four nephrometries were moderately to strongly correlated with each other. The strongest correlations were between CSA and C-index (coefficient: − 0.885, p < 0.001), followed by R.E.N.A.L. and PADUA (coefficient: 0.778, p < 0.001). Ischemia time was significantly correlated with R.EN.A.L. (coefficient: 0.35, p = 0.025), PADUA (coefficient:0.42, p = 0.007), C-index (coefficient: − 0.45, p = 0.004), and CSA (coefficient: 0.41, p = 0.009). Operative time was correlated with C-index (coefficient: − 0.34, p = 0.037) and CSA (coefficient: 0.37, p = 0.018), and PCE of the operated kidney was correlated with PADUA (coefficient: 0.48 p = 0.002), C-index (coefficient: − 0.74, p < 0.001), and CSA (coefficient: 0.75, p < 0.001). However weaker correlation coefficients for PCE/ ACE were noted in PADUA compared with C-index and CSA (Table 3).
In univariate analysis, operative time, R.E.N.A.L., PADUA, and C-index significantly affected ischemia time. However, only PADUA (p = 0.04) significantly affected ischemia time in multivariate analysis (Table 4). Ischemia time, PADUA, C-index, and CSA affected PCE of the operated kidney in univariate analysis, while only C-index (p = 0.03) and CSA (p = 0.005) influenced PCE of the operated kidney independently (Table 5). The predictive value for PCE20 of C-index and CSA were evaluated via ROC curve analysis, in which both C-index and CSA were equally able to predict the PCE20 (AUC: 0.91 vs 0.86, p = 0.2). The cut off values of PCE20 derived from Youden’s index were 2.11 for C-index and 10.37 cm2 for CSA.
In recent decades, a few studies have focused on factors impacting functional changes after PN, and identified both unmodifiable and modifiable factors . The two most important modifiable factors, ischemia time and renal volume preservation, indicate the quality and quantity of the affected kidney, respectively . The correlation between post-operative global renal function and different nephrometry systems varies from study to study [9, 11]. Furthermore, few head-to-head comparisons of the predictive ability of IPRF between different nephrometries have been reported. To the best of our knowledge, this is the first study to compare correlations between different nephrometries and IPRF. In this study, the four nephrometries were correlated with peri-operative outcomes and IPRF. In addition, we found that PADUA could significantly predict the ischemia time, while C-index and CSA independently affected IPRF.
The indication for PN has progressed from small renal masses to renal tumors < 7 cm in size [1, 2]. Contralateral kidney compensation becomes significant with greater parenchymal loss in patients with larger renal tumors . Traditional models used to calculate eGFR according to serum creatinine have limitations such as estimation errors and inconsistencies, and therefore eGFR is suboptimal to assess functional outcomes . Thus, assessing ipsilateral renal function using radio-isotope scans has become the standard evaluation method [1, 2]. Takagi et al. studied patients with small renal masses with a median size of 3.5 cm, which is similar to our study. In their study, the percent eGFR changes in operated and contralateral kidneys were − 24.4 and + 2.29%, respectively . Other series have also reported that about 72–80% renal function preservation in the operated kidney . The volume of renal preservation has been shown to be more important than ischemia time for long-term renal function in recent studies [17, 19].
Perioperative outcomes and different nephrometries have been highly correlated . Borgmann et al. demonstrated that surgical complexity and trifecta of PN were better assessed by R.E.N.A.L score than C-index . In the current study, PADUA nephrometry significantly affected ischemia time, while C-index and CSA did not. This may be because ischemia time reflects the surgical complexity, which involves the tumor location and sinus or collecting system invasion. In addition, it is better described by the comprehensive multiple anatomical factors included in PADUA. Recently Ficarra et al. proposed an updated version of PADUA, the Simplified PADUA REnal (SPARE) nephrometry, which exerts similar predictive ability of complication. Compared with CSA, SPARE nephrometry is not an independent predictor of renal function impairment . It is possible that multiple factors with equal weights in the PADUA system may weaken the power in predicting IPRF.
Kwon et al. and Yoo et al. reported that R.E.N.A.L. was an independent predictor of IPRF as measured by 99mTc DTPA [22, 23]. In contrast to their study, R.E.N.A.L. score in our cohort was not a significant predictor of IPRF. The difference may be because the previous study treated the R.E.N.A.L. score as a binary variable and analyzed it with different ischemic types in linear multivariate analysis . More importantly, the quality of 99mTc MAG3 images as used in our study has been reported to be superior to scans obtained using 99mTc DTPA in patients with diseased kidneys [15, 18]. A recent study further revealed that only the constituents of “R” and “E” in R.E.N.A.L nephrometry instead of total score were associate with ipsilateral renal function . These two constituents are included in CSA and C-index.
Simmon et al. reported that C-index affected the nadir and late eGFR . Samplaski et al. further reported that a C-index cut-off value < 2.5 increased the probability of a 30% decline in global renal function by 2.2-fold . Another study reported that C-index outperformed R.E.N.A.L. score in predicting global renal function loss [10, 26]. To the best of our knowledge, this study is the first cohort study to evaluate the predictive ability of IPRF using C-index. Several potential reasons may explain the difference in cut-off value (2.5 vs 2.1) to predict renal functional loss. First, different methodologies were applied to yield cut-off values in the previous study . Second, greater global function loss was reported in the previous study compared to in our cohort . Third, split renal function is more sensitive than eGFR, so the cut-off value for the same percentage of functional reduction may be smaller.
Both CSA and C-index described the degree of tumor invasion and had the common factor of tumor size. Moreover, depth(d) in CSA and distance(c) in C-index are very closely related. Our study further proved this concept because these two nephrometries were highly correlated (coefficient: − 0.885, p < 0.001). The impact of CSA and C- index on IPRF is supported by evidence showing that tumor size and depth are the most important prognostic factors of ipsilateral renal function . The interplay between volume, CSA, and C-index is described in Fig. 1. The distance between tumor and kidney center (c) consists of tumor radius (r) and nearest distance between tumor margin and kidney center (k). Depth (d) implies the volume of resected renal parenchyma, and CSA was shown to be correlated with resected and ischemic renal volume in our previous study . In addition, “k” implies the thickness of residual renal parenchyma, and C-index has been shown to be correlated with percent functional volume preservation . Lee et al. found that CSA and C-index independently affected the percent reduction in renal cortical volume.  Therefore, both CSA and C-index were effective in predicting IPRF based on mathematical volume theory.
The strength of this study is that it is the first cohort study to compare ipsilateral functional outcomes among four nephrometries. In contrast to previous studies we provided more precise data derived from 99mTc MAG3 studies. Moreover, we directly compared the ability and provided cut-off values to predict functional changes for both CSA and C-index. There are also several limitations in this study. First, it was a retrospective design with a relatively small number of cases, and therefore selection bias was possible which may have resulted in confined tumor complexity and may be not representative the experience of other centers. However, the tumor complexity in our cohort was similar to previous studies [11, 20]. Although the follow-up time was only 1 year, Porpiglia et al. showed that ERPF remained stable 3 months after surgery . Second, some of the renal tumors in our study were angiomyolipoma or other benign histology. However, the degree of global renal functional change in patients with angiomyolipoma after PN has shown to be similar to RCC . Third, the PN technique such as enucleation and wedge resection was not unified. Therefore, further studies are needed to evaluate relationships among different nephrometries and pathologic or radiographic renal volume.
Based on the results of this study and the different characteristics of each nephrometry systems, we suggest using PADUA nephrometry to evaluate surgical complexity and ischemia time. Regarding the precise prediction of IPRF, we recommend using both CSA and C-index, as this may have greater predictive ability than R.E.N.A.L. and PADUA nephrometries.
Availability of data and materials
The data supporting the conclusions are contained within the manuscript. The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
Absolute change of ERPF
Mathematical tumor contact surface area
Diethylene triamine penta-acetic acid
estimated glomerular filtration rates
Effective renal plasma flow
Ipsilateral post-operative renal function
Laparoscopic partial nephrectomy
Tc-99 m mercaptoacetyltriglycine
Open partial nephrectomy
Percent change of ERPF
Robotic-assisted laparoscopic partial nephrectom
Ljungberg B, Albiges L, Bensalah K, Bex A, Giles RH, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, et al. EAU Guidelines on Renal Cell Carcinoma 2018. In: European Association of Urology guidelines 2018 edition. Volume presented at the EAU annual congress Copenhagen 2018, edn. Arnhem. The Netherlands: European Association of Urology Guidelines Office; 2018.
NCCN Guidlines Version 2.2019 Kidney Cancer [https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf].
Capitanio U, Terrone C, Antonelli A, Minervini A, Volpe A, Furlan M, Matloob R, Regis F, Fiori C, Porpiglia F, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015;67(4):683–9.
Tan HJ, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;307(15):1629–35.
Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844–53.
Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, Artibani W. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56(5):786–93.
Simmons MN, Ching CB, Samplaski MK, Park CH, Gill IS. Kidney tumor location measurement using the C index method. J Urol. 2010;183(5):1708–13.
Hsieh PF, Wang YD, Huang CP, Wu HC, Yang CR, Chen GH, Chang CH. A mathematical method to calculate tumor contact surface area: an effective parameter to predict renal function after partial nephrectomy. J Urol. 2016;196(1):33–40.
Bylund JR, Gayheart D, Fleming T, Venkatesh R, Preston DM, Strup SE, Crispen PL. Association of tumor size, location, R.E.N.A.L., PADUA and centrality index score with perioperative outcomes and postoperative renal function. J Urol. 2012;188(5):1684–9.
Spaliviero M, Poon BY, Aras O, Di Paolo PL, Guglielmetti GB, Coleman CZ, Karlo CA, Bernstein ML, Sjoberg DD, Russo P, et al. Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems. World J Urol. 2015;33(6):853–8.
Gupta R, Tori M, Babitz SK, Tobert CM, Anema JG, Noyes SL, Lane BR. Comparison of RENAL, PADUA, CSA, and PAVP Nephrometry scores in predicting functional outcomes after partial nephrectomy. Urology. 2019;124:160–7.
Takagi T, Mir MC, Sharma N, Remer EM, Li J, Demirjian S, Kaouk JH, Campbell SC. Compensatory hypertrophy after partial and radical nephrectomy in adults. J Urol. 2014;192(6):1612–9.
Sankin A, Sfakianos JP, Schiff J, Sjoberg D, Coleman JA. Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate. Urology. 2012;80(2):343–6.
Zargar H, Akca O, Autorino R, Brandao LF, Laydner H, Krishnan J, Samarasekera D, Stein RJ, Kaouk JH. Ipsilateral renal function preservation after robot-assisted partial nephrectomy (RAPN): an objective analysis using mercapto-acetyltriglycine (MAG3) renal scan data and volumetric assessment. BJU Int. 2015;115(5):787–95.
Taylor AT. Radionuclides in nephrourology, part 1: radiopharmaceuticals, quality control, and quantitative indices. J Nucl Med. 2014;55(4):608–15.
Watts KL, Ghosh P, Stein S, Ghavamian R. Value of Nephrometry score constituents on perioperative outcomes and Split renal function in patients undergoing minimally invasive partial nephrectomy. Urology. 2017;99:112–7.
Mir MC, Ercole C, Takagi T, Zhang Z, Velet L, Remer EM, Demirjian S, Campbell SC. Decline in renal function after partial nephrectomy: etiology and prevention. J Urol. 2015;193(6):1889–98.
Volpe A, Blute ML, Ficarra V, Gill IS, Kutikov A, Porpiglia F, Rogers C, Touijer KA, Van Poppel H, Thompson RH. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol. 2015;68(1):61–74.
Ginzburg S, Uzzo R, Walton J, Miller C, Kurz D, Li T, Handorf E, Gor R, Corcoran A, Viterbo R, et al. Residual parenchymal volume, not warm ischemia time, predicts ultimate renal functional outcomes in patients undergoing partial nephrectomy. Urology. 2015;86(2):300–5.
Borgmann H, Reiss AK, Kurosch M, Filmann N, Frees S, Mager R, Tsaur I, Haferkamp A. R.E.N.A.L. score outperforms PADUA score, C-index and DAP score for outcome prediction of nephron sparing surgery in a selected cohort. J Urol. 2016;196(3):664–71.
Ficarra V, Porpiglia F, Crestani A, Minervini A, Antonelli A, Longo N, Novara G, Giannarini G, Fiori C, Simeone C, et al. The simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy. BJU Int. 2019; https://doi.org/10.1111/bju.14772.
Kwon T, Jeong IG, Ryu J, Lee C, Lee C, You D, Kim CS. Renal function is associated with Nephrometry score after partial nephrectomy: a study using diethylene Triamine Penta-acetic acid (DTPA) renal scanning. Ann Surg Oncol. 2015;22(Suppl 3):S1594–600.
Yoo S, Lee C, You D, Jeong IG, Kim CS. Comparison of renal functional outcomes in exactly matched pairs between robot-assisted partial nephrectomy using warm ischemia and open partial nephrectomy using cold ischemia using diethylene triamine penta-acetic acid renal scintigraphy. Int Urol Nephrol. 2016;48(5):687–93.
Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Nephrometry score is associated with volume loss and functional recovery after partial nephrectomy. J Urol. 2012;188(1):39–44.
Samplaski MK, Hernandez A, Gill IS, Simmons MN. C-index is associated with functional outcomes after laparoscopic partial nephrectomy. J Urol. 2010;184(6):2259–63.
Sugiura M, Suyama T, Kanesaka M, Fujimoto A, Hou K, Araki K, Masuda H, Kojima S, Naya Y. Usefulness of R.E.N.a.L Nephrometry scoring system and centrality index score for predicting outcome of laparoscopic partial nephrectomy. J Laparoendosc Adv Surg Tech A. 2016;26(10):784–8.
Chan AA, Wood CG, Caicedo J, Munsell MF, Matin SF. Predictors of unilateral renal function after open and laparoscopic partial nephrectomy. Urology. 2010;75(2):295–302.
Wang YD, Chang CH, Huang CP, Wu HC, Yang CR, Hsieh PF. New-generation nephrometry systems: head-to-head comparison of tumor contact surface area and resected and ischemic volume. Urol Sci. 2017;28(2):84–8.
Lee CH, Ku JY, Park YJ, Seo WI, Ha HK. The superiority of contact surface area as a predictor of renal cortical volume change after partial nephrectomy compared to RENAL, PADUA and C-index: an approach using computed tomography-based renal volumetry. Scand J Urol. 2019;53(2–3):129–33.
Porpiglia F, Fiori C, Bertolo R, Morra I, Russo R, Piccoli G, Angusti T, Podio V. Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. Eur Urol. 2012;62(1):130–5.
Lin CY, Yang CK, Ou YC, Chiu KY, Cheng CL, Ho HC, Wang SS, Chen CS, Li JR. Long-term outcome of robotic partial nephrectomy for renal angiomyolipoma. Asian J Surg. 2018;41(2):187–91.
The authors would like to thank China Medical University Hospital for providing the opportunity to conduct this study.
Ethics approval and consent to participate
This study was approved by the Ethical Committee of China Medical University Hospital (CMUH108-REC3–063). Consent to participate was not applicable due to the retrospective nature of this study.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wang, Y., Huang, C., Chang, C. et al. The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting ipsilateral renal function after partial nephrectomy. BMC Urol 19, 72 (2019). https://doi.org/10.1186/s12894-019-0504-2
- Contact surface area
- Partial nephrectomy
- Renal function
- Renal scintigraphy